ZN
ZNTL
Zentalis Pharmaceuticals, Inc. - common stock
NASDAQMarket Cap
P/E Ratio
19.07
Dividend Yield
1.07%
Volume
52W High
52W Low
Avg Volume
Financial Statements
What does this mean?Income statement, balance sheet, and cash flow over time
| Metric | |
|---|---|
No financial data available
Institutional Ownership
What does this mean?Top institutions holding ZNTL
| Institution | Shares Held | Value | Date |
|---|---|---|---|
| Vanguard Group | 150,000,000 | $25,000,000,000 | Nov 2025 |
| BlackRock | 140,000,000 | $23,500,000,000 | Nov 2025 |
| State Street | 80,000,000 | $13,500,000,000 | Nov 2025 |
| Fidelity | 65,000,000 | $11,000,000,000 | Oct 2025 |
| Geode Capital | 35,000,000 | $5,900,000,000 | Oct 2025 |
ETF Holdings
What does this mean?Top ETFs holding ZNTL
| ETF | Weight | Shares |
|---|---|---|
| QQQ | 8.50% | 18,078,486 |
| VGT | 6.20% | 9,753,875 |
| SPY | 4.50% | 7,402,691 |
| IVV | 4.20% | 31,050,310 |
| VOO | 3.80% | 7,429,040 |
Trade
Buy/Sell via broker links (affiliate).
Trading 212
Paper Trade
Save a buy/sell to your portfolio tracker (not a real trade).
Sign in
to save trades to your portfolio tracker.
Paper Orders
Limit/stop reminders, with optional bracket (take profit + stop loss).
Sign in
to place paper orders.
Price Alerts
Notify when ZNTL crosses your target.
Sign in
to create alerts and sync them across devices.
Company Info
What does this mean?About
Zentalis Pharmaceuticals, Inc. - common stock (ZNTL) is included in the Stock Monitor database for research and watchlists.
CEO
N/A
Employees
107,107
IPO Date
Jan 1, 2000
Analyst Ratings
What does this mean?JPMorgan
Dec 6, 2025
Hold
Bernstein
Nov 19, 2025
Hold
Piper Sandler
Nov 2, 2025
Overweight
Goldman Sachs
Oct 11, 2025
Buy
Morgan Stanley
Sep 24, 2025
Buy
Price Target
$70.03